Only half of participants who were exposed to the coronavirus developed infections, most with mild symptoms.
Study participants reported symptoms typical of other respiratory infections, such as runny noses and sore throats. Fevers were less common.Healthy, young people who were intentionally exposed to the coronavirus SARS-CoV-2 developed mild symptoms — if any — in a first-of-its-kind COVID-19 human-challenge study. Such trials present a unique opportunity to study viral infections in detail from start to finish, but are controversial because of the risks they pose to participants.
However, some researchers question whether the insights yielded by the study so far are important enough to justify the risks to participants, such as the potential for long-term side effects. “In my mind, it’s still not entirely clear whether these studies are ethically justified, and I’m waiting to see what else they’ve found,” says Seema Shah, a bioethicist at Northwestern University in Chicago, Illinois.
The most common symptoms were typical of other respiratory infections: sore throats, runny noses and sneezing. Fever was less common, and no one developed the persistent cough that had been used as a hallmark of COVID-19, says Catchpole. Around 70% of infected participants lost their senses of smell or taste — another COVID-19 signature — to varying degrees. Such problems persisted for more than six months in five participants and more than nine months in one.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
South African scientists copy Moderna’s COVID vaccineResearchers at WHO technology-transfer hub complete first step in a project aimed at building capacity for vaccine manufacturing in low- and middle-income countries.
Lire la suite »
Scientists demand new investigation of COVID-19 origins ahead of Beijing OlympicsAn open letter from 20 international scientists demands a comprehensive and transparent investigation into Covid-19's origins ahead of the Beijing Olympics.
Lire la suite »
South African scientists copy Moderna’s COVID vaccineResearchers at WHO technology-transfer hub complete first step in a project aimed at building capacity for vaccine manufacturing in low- and middle-income countries.
Lire la suite »
Medicare opens up access to free at-home COVID-19 testsThe Biden administration says people with Medicare will be able to get up to eight free over-the-counter COVID-19 tests per month, starting in early spring.
Lire la suite »
CDC launches COVID-19 wastewater surveillance dashboard
Lire la suite »
Though Rare, Moderna Covid Vaccine Recipients Have Higher Risk of Heart Inflammation Than PfizerA CDC survey of health-care providers found that 81% of their patients who developed myocarditis after vaccination completely or probably recovered.
Lire la suite »